Cite
HARVARD Citation
Chavan, A. et al. (2021). Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Vadadustat, an Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor. Clinical pharmacology in drug development. 10 (8), pp. 950-958. [Online].